Keryx raises $69.9M in bumped-up follow-on

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) raised $69.9 million through the sale of 8.2 million shares at $8.49 in a bumped-up follow-on underwritten by JPMorgan; Barclays; Citigroup; Oppenheimer; Stifel Nicolaus Weisel; JMP Securities; Roth Capital Partners; Brean Capital; and Ladenburg Thalmann. Keryx said it planned to raise $55 million in a follow-on late Tuesday, when its share price was $8.36. Keryx was up $0.59 to $9.08 on Thursday. ...